Meeting
2019 ASCO Annual Meeting
Benefit of combining local treatment and systemic therapy for stage IV NSCLC: Results from the National Cancer Database.
Authors
Meaghan Dendy Case
Yale University School of Medicine, New Haven, CT
Meaghan Dendy Case , Johannes Uhlig , Justin Blasberg , Daniel J. Boffa , Anne C. Chiang , Scott N. Gettinger , Hyun S. Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 8545)
DOI
10.1200/JCO.2019.37.15_suppl.8545
Abstract #
8545
Poster Bd #
301
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Healthcare contact days for patients with stage IV non-small cell lung cancer (NSCLC) in Ontario: A population-based study.
First Author: Arjun Gupta
Poster
2021 ASCO Quality Care Symposium
Overall survival benefits of advances in NSCLC systemic treatments: Younger versus older adults.
First Author: Bonnie Leung
Poster
2021 ASCO Annual Meeting
Population-based impacts of new therapies on outcomes for stage IV non-small cell lung cancer.
First Author: Rebekah Rittberg
Poster
2020 ASCO Virtual Scientific Program
RAS-mutated sporadic medullary thyroid cancer: A single-center experience.
First Author: Spandana Brown